Another study used a 64Cu-NOTA-mouse anti-PD-1 IgG2a (RMP1-14) PET tracer and found similar results with high uptake in the tumor, blood, liver, kidney and spleen 24 hours post-injection 100. This evidence concerns the gene PDCD1 and neoplasm.